Navigation Links
Transplant helps diabetes

Type I diabetes, is a type of disease, that requires insulin injections daily. Researchers are slowly heading towards closer to a cure for this disease. Some medical research centers in the U.S. and Europe conducted experiments on people with severe Type I diabetes by transplanting insulin-producing islet cells combined with less toxic antirejection drugs. These people are able to live normal lives without insulin.

A.M. James Shapiro, MD, a Canadian surgeon, director of the clinical islet and pancreas transplant programs at the University of Alberta in Edmonton , pioneered this technique called the Edmonton Protocol.//

After one year, the follow-up data of the subjects showed positive and welcoming results. The results showed that out of 15 people with type I diabetes who have undergone this technique, two-thirds of them were insulin-free.These findings were recently presented by Shapiro, at the annual meeting of the American Diabetes Association in Philadelphia.

Other researchers and Shapiro's team are currently working on improving the protocol mainly by developing better immunosupressing, antirejection drugs that are less toxic to islet cells. Since islets are considered foreign to the host, drugs have to be used to prevent the body from rejecting the cells.Sometimes these may cause further kidney problems in individuals with long-standing diabetes.

People with Type I diabetes either do not make any insulin or only make tiny amounts. Hence, they require daily shots of insulin to live. This type of disease often leads to life-threatening complications such as blindness, kidney failure, and heart disease. The Edmonton protocol has been replicated successfully in centers in the U.S. and Europe.

Another opiton is a whole pancreas transplant which will eliminate the need of insulin injections. Since only a few thousand pancreases are donated in the U.S. each year, the operation is cumbersome.

Shapiro feels that patients do much better with Edmonton protocol than transplants. Another hurdle on the road toward a cure is that there are not enough islet cells to go around. The Edmonton technique actually requires islet cells from two donor pancreases for each patient transplanted. Shapiro feels that since there is tremendous excitement with stem cell research, they suggested that islet cells could be easily replicated in the lab, and hence there would be a limitless source of cells.

Shapiro feels that if this can become the truth, there can be a permanent cure for type I diabetes patients as well as type II diabetes.


'"/>




Related medicine news :

1. Stem Cell Transplants May Be Effective For MS Patients
2. Drugs Deter Heart Disease for Transplant Patients
3. Better Drug for Heart Transplant
4. Kidney Failure after Non-Kidney Transplants
5. Measles Risk in Transplant Patients
6. Transplants Help Liver Cancer Patients
7. Steroid-Free Liver Transplants
8. Pancreas Transplant for Diabetics
9. Reducing The Risk Of Fractures After a Heart Transplant
10. A Urine Test Could Predict Rejection In Transplant Patients
11. Thawed Ovarian Transplant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, ... development and joint health in horses at the immunologic level. , The scientifically-developed ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 6.35% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: